An update from Moleculin Biotech (MBRX) is now available.
Moleculin Biotech, Inc. is sharing a corporate presentation on its website, which provides an update on the company’s status without constituting an official filing under the Securities Exchange Act of 1934. The information is intended for current and potential investors to understand the company’s progress and is not meant for formal regulatory purposes.
See more insights into MBRX stock on TipRanks’ Stock Analysis page.
